RB
Desconocido
PREMIER: Prioritisation and Risk Evaluation of Medicines in the EnviRonment
RECKITT BENCKISER LIMITED
participó en un
H2020:
H2020-JTI-IMI2-2019-17-two-stage
There are around 1900 active pharmaceutical ingredients (APIs) in use, yet the environmental risks of only a small proportion of these has b...
2020-06-24 - 2026-08-31 | Financiado
2020-06-24 - 2026-08-31 | Financiado
GROWTH: Research and Training in Early Life Nutrition to Prevent Disease
RECKITT BENCKISER LIMITED
participó en un
H2020:
H2020-MSCA-ITN-2018
The interplay between nutrition, gut microbiota, and its large numberof metabolic and immune mediators plays an essential role in the develo...
2018-07-31 - 2024-04-30 | Financiado
2018-07-31 - 2024-04-30 | Financiado
* No se disponen de datos de la empresa actual.